A glycosylated, labionin-containing lanthipeptide with marked antinociceptive activity.
about
Bioengineering Lantibiotics for Therapeutic SuccessMechanistic studies on the substrate-tolerant lanthipeptide synthetase ProcMStructure and mechanism of lanthipeptide biosynthetic enzymes.Genome mining for ribosomally synthesized and post-translationally modified peptides (RiPPs) in anaerobic bacteria.Expanded natural product diversity revealed by analysis of lanthipeptide-like gene clusters in actinobacteriaNew Insights into the Biosynthetic Logic of Ribosomally Synthesized and Post-translationally Modified Peptide Natural Products.Discovering new bioactive molecules from microbial sources.Growing the seeds sown by Piero Sensi.Advancing cell wall inhibitors towards clinical applications.Employing the promiscuity of lantibiotic biosynthetic machineries to produce novel antimicrobials.Pharmacological and pharmacokinetic properties of lanthipeptides undergoing clinical studies.Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes.Actinoplanes Swims into the Molecular Age.Phage display and selection of lanthipeptides on the carboxy-terminus of the gene-3 minor coat protein.Improving the attrition rate of Lanthipeptide discovery for commercial applications.High production of a class III lantipeptide AmfS in Streptomyces griseus.
P2860
Q26774123-2CF3C102-A8CD-48E2-99F2-202962A02D6FQ33951197-CDEB5650-15BD-48D9-9122-709F86E69EEBQ34713865-D344C31B-3697-499A-AA5F-915E939F4C64Q35433857-2C332140-E187-4977-A65B-A84060719502Q35764125-91C67FC0-82BD-4624-9C51-6F52DF7150E0Q36654180-80F660AE-3FCD-40F7-9181-F2CA16DD7B02Q38198771-6BC2D767-C654-4AA8-BAD8-2215FE1B6AB8Q38239458-EE23B89E-D4F3-42F2-B86F-EBACE7CD5B8CQ38620000-067A304C-8DAA-4D1C-AE51-EB99BF389E50Q38945513-CAE69C68-E697-427B-A6C9-4304B441A09CQ39065285-0EC6C7CF-8463-4C2B-B258-5E8800A6D986Q39109460-7E70E0FB-9787-4FAC-8F3B-9329EF8E46E4Q45162574-56381F1B-2F24-4096-9AC9-8279A08A579BQ47134907-297170BE-5C16-4FD5-B2B5-196521B8954BQ47383314-85A4C8D3-0EB1-4A69-9A5E-258C687170AFQ51149135-B0470D66-3C5D-4CC9-995A-AAA7AAE0F22A
P2860
A glycosylated, labionin-containing lanthipeptide with marked antinociceptive activity.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
A glycosylated, labionin-containing lanthipeptide with marked antinociceptive activity.
@en
A glycosylated, labionin-containing lanthipeptide with marked antinociceptive activity.
@nl
type
label
A glycosylated, labionin-containing lanthipeptide with marked antinociceptive activity.
@en
A glycosylated, labionin-containing lanthipeptide with marked antinociceptive activity.
@nl
prefLabel
A glycosylated, labionin-containing lanthipeptide with marked antinociceptive activity.
@en
A glycosylated, labionin-containing lanthipeptide with marked antinociceptive activity.
@nl
P2093
P50
P356
P1433
P1476
A glycosylated, labionin-containing lanthipeptide with marked antinociceptive activity
@en
P2093
Angelo Reggiani
Cristina Brunati
Daniele Piomelli
Fabiola Bonezzi
Glauco Tarozzo
Marianna Iorio
Oscar Sasso
Paolo Monciardini
Roberta Bordoni
Sonia I Maffioli
P304
P356
10.1021/CB400692W
P577
2013-11-20T00:00:00Z